Real-world, 52-week prospective study to capture the reasons for switch to triple combination therapy, assess the clinical and patient reported outcomes in adults with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) treated with Trixeo Aerosphere™ in routine care settings in Greece

Trial Identifier: D5980R00082
Sponsor: AstraZeneca
NCTID:: NCT05915182
Start Date: July 2023
Primary Completion Date: May 2025
Study Completion Date: May 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Greece Alexandroupoli, Greece, 68100
Greece Athens, Greece, 17562
Greece Athens, Greece, 11521
Greece Athens, Greece, 11527
Greece Crete, Greece, 73300
Greece Crete, Greece, 71500
Greece Ioannina, Greece, 45500
Greece Patra, Greece, 26504
Greece Thessaloniki, Greece, 54642
Greece Thessaloniki, Greece, 57010